Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

[1]  J. Kim,et al.  In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. , 1997, Journal of immunology.

[2]  D. Carson,et al.  Gene vaccination with naked plasmid DNA: mechanism of CTL priming , 1996, The Journal of experimental medicine.

[3]  R. Flavell,et al.  Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues , 1996, Journal of virology.

[4]  C. Walker,et al.  Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Weiner,et al.  In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunization , 1996, Journal of medical primatology.

[6]  D. Pardoll,et al.  Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? , 1996, The Journal of experimental medicine.

[7]  D. Curiel,et al.  Selected strategies to augment polynucleotide immunization. , 1996, Gene therapy.

[8]  E. Jaffee,et al.  A reassessment of the role of B7-1 expression in tumor rejection , 1995, The Journal of experimental medicine.

[9]  D. Pardoll,et al.  Exposing the immunology of naked DNA vaccines. , 1995, Immunity.

[10]  M. Battegay,et al.  Fibroblasts as efficient antigen-presenting cells in lymphoid organs. , 1995, Science.

[11]  R. Welsh,et al.  Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. , 1995, Journal of immunology.

[12]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[13]  S. Yerly,et al.  Response of HIV RNA to didanosine as a predictive marker of survival , 1995, AIDS.

[14]  P. Linsley,et al.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.

[15]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[16]  J. Bluestone,et al.  IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. , 1994, Journal of immunology.

[17]  R. Hohlfeld,et al.  The immunobiology of muscle. , 1994, Immunology today.

[18]  P. Linsley,et al.  Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. , 1994, Journal of immunology.

[19]  N. Chirmule,et al.  Improved specificity of in vitro anti-HIV antibody production: implications for diagnosis and timing of transmission in infants born to HIV-seropositive mothers. , 1994, AIDS research and human retroviruses.

[20]  E. Jaffee,et al.  Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.

[21]  Bin Wang,et al.  DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. , 1994, AIDS research and human retroviruses.

[22]  H L Robinson,et al.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[24]  H. Davis,et al.  DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. , 1993, Human molecular genetics.

[25]  V. Ramesh,et al.  Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. , 1993, Human molecular genetics.

[26]  R. Hohlfeld,et al.  Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. , 1993, The American journal of pathology.

[27]  H. Margolis.  Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. , 1993, The Journal of infectious diseases.

[28]  Bin Wang,et al.  Gene inoculation generates immune responses against human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[30]  D. Weiner,et al.  Induction of cell differentiation by human immunodeficiency virus 1 vpr , 1993, Cell.

[31]  J. Berzofsky,et al.  Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. , 1992, Journal of immunology.

[32]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[33]  T. Partridge,et al.  Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. , 1992, The American journal of pathology.

[34]  L. Lanier,et al.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.

[35]  R A Houghten,et al.  Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. , 1992, Science.

[36]  R. Hohlfeld,et al.  Human myoblasts as antigen presenting cells , 1991, Journal of Neuroimmunology.

[37]  G. Freeman,et al.  Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.

[38]  H. Blau,et al.  Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN‐γ , 1991, Neurology.

[39]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[40]  J. Bouchard,et al.  Expression of major histocompatibility complex antigens on human myoblasts. , 1991, Transplantation proceedings.

[41]  Agadjanyan Mg,et al.  Role of antigen-binding B lymphocytes in the formation of antigen-dependent nonspecific immunoglobulin-forming cells. , 1991 .

[42]  F. Brodsky,et al.  The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.

[43]  P. Linsley,et al.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[45]  R. Hohlfeld,et al.  Induction of HLA-DR expression on human myoblasts with interferon-gamma. , 1990, The American journal of pathology.

[46]  H. Blau,et al.  Isolation and characterization of human muscle cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.